arrow
S

Sarah Schemmert

priavoid gmbh
H指数:10
被引数:366

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

α-Synuclein Aggregate-Disassembling Compounds Prolong Survival in a Mouse Model of Parkinson's Disease

α-突触核蛋白聚集解聚化合物延长帕金森病小鼠模型的生存期

Aggregate
IF13.7
2026-09-190
OAAI
Pharmacokinetic properties of the clinical drug candidate PRI-002 with regard to genotype, sex, age, dose-dependence and food effects in mice.

临床候选药物PRI-002的药代动力学特性,涉及基因型、性别、年龄、剂量依赖性和食物效应在小鼠中的研究

2026-09-030
OAAI
Oral treatment with the all-D-peptide RD2 enhances cognition in aged beagle dogs - A model of sporadic Alzheimer's disease

用全D肽RD2口服治疗可增强老年比格犬的认知能力-散发性阿尔茨海默氏病模型

HELIYON
IF3.6
2023-08-011
OAAI
Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer's Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography

Florbetaben正电子发射断层扫描定量的两种转基因阿尔茨海默病小鼠模型大脑中淀粉样蛋白负荷的比较

2021-10-045
OAAI
Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2

通过口服消除a β 寡聚体的化合物RD2,使焦谷氨酸-a β 积累的转基因小鼠的神经变性表型减速

2019-04-0113
OAAI